Literature DB >> 23401108

Post-mortem apparent resolution of fetal ventriculomegaly: evidence from magnetic resonance imaging.

Neil J Sebire1, Sarah Miller, Thomas S Jacques, Andrew M Taylor, Janet M Rennie, Giles Kendall, Lyn S Chitty.   

Abstract

OBJECTIVE: This study aims to determine the accuracy of post-mortem magnetic resonance imaging (MRI) and autopsy for confirmation of sonographically detected fetal ventriculomegaly.
METHODS: This study uses retrospective review of fetuses with sonographically diagnosed ventriculomegaly, where the pregnancy was terminated and post-mortem examination was performed during a period in which post-mortem MRI was being offered.
RESULTS: Sixteen cases were identified. In nine (56%), autopsy and/or post-mortem MRI confirmed the prenatal findings. In the other seven, both autopsy and post-mortem MRI demonstrated no ventriculomegaly, but antenatal MRI confirmed the ultrasound findings in 6/7 cases where it had been performed. Post-mortem investigations confirmed antenatal findings in 8/9 cases with severe ventriculomegaly (posterior horn measurement >15 mm), whereas only 2/7 in which ventriculomegaly was not confirmed had severe ventriculomegaly.
CONCLUSIONS: Post-mortem examination, both by traditional neuropathological examination, and post-mortem MRI may fail to confirm prenatal ventriculomegaly in around half of cases. The post-mortem MRI findings indicate that this is due to resolution of ventriculomegaly rather than autopsy artefact, and is presumably a consequence of post-mortem fluid redistribution. Parents should be advised before termination of pregnancy that post-mortem confirmation of ventriculomegaly, especially in mild cases, may not be possible. Antenatal MRI may be a better approach for confirming prenatal ultrasound findings.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23401108     DOI: 10.1002/pd.4065

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Intrauterine fetal MR versus postmortem MR imaging after therapeutic termination of pregnancy: evaluation of the concordance in the detection of brain abnormalities at early gestational stage.

Authors:  Giana Izzo; Giacomo Talenti; Giorgia Falanga; Marco Moscatelli; Giorgio Conte; Elisa Scola; Chiara Doneda; Cecilia Parazzini; Mariangela Rustico; Fabio Triulzi; Andrea Righini
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

Review 2.  Indications, advantages and limitations of perinatal postmortem imaging in clinical practice.

Authors:  Owen J Arthurs; Andrew M Taylor; Neil J Sebire
Journal:  Pediatr Radiol       Date:  2014-10-02

Review 3.  Perinatal post mortem ultrasound (PMUS): a practical approach.

Authors:  Susan C Shelmerdine; Neil J Sebire; Owen J Arthurs
Journal:  Insights Imaging       Date:  2019-03-18

4.  Diagnostic assessment of foetal brain malformations with intra-uterine MRI versus perinatal post-mortem MRI.

Authors:  Stacy K Goergen; Ekaterina Alibrahim; Nishentha Govender; Alexandra Stanislavsky; Christian Abel; Stacey Prystupa; Jacquelene Collett; Susan C Shelmerdine; Owen J Arthurs
Journal:  Neuroradiology       Date:  2019-05-10       Impact factor: 2.804

Review 5.  Perinatal post-mortem ultrasound (PMUS): radiological-pathological correlation.

Authors:  Susan C Shelmerdine; Neil J Sebire; Owen J Arthurs
Journal:  Insights Imaging       Date:  2019-08-21

Review 6.  Paediatric and perinatal postmortem imaging: the need for a subspecialty approach.

Authors:  Owen J Arthurs; Rick R van Rijn; Andrew M Taylor; Neil J Sebire
Journal:  Pediatr Radiol       Date:  2014-08-30

7.  Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies.

Authors:  Elizabeth Quinlan-Jones; Jenny Lord; Eamonn R Maher; Matthew E Hurles; Mark D Kilby; Denise Williams; Sue Hamilton; Tamas Marton; Ruth Y Eberhardt; Gabriele Rinck; Elena Prigmore; Rebecca Keelagher; Dominic J McMullan
Journal:  Genet Med       Date:  2018-10-08       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.